PAX5 and hepatocellular carcinoma: In 2011, our collaborators reported that PAX5, a functional tumor suppressor involved in liver carcinogenesis through direct regulation of the p53 signaling pathway, was frequently inactivated by promoter methylation in primary hepatocellular carcinoma tissues [7].